Copyright Reports & Markets. All rights reserved.

Global Medical In-Vitro Toxicology Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Medical In-Vitro Toxicology Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Medical In-Vitro Toxicology Testing by Type
    • 1.3.1 Overview: Global Medical In-Vitro Toxicology Testing Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Medical In-Vitro Toxicology Testing Consumption Value Market Share by Type in 2022
    • 1.3.3 Cell Culture Technology
    • 1.3.4 High Throughput Technology
    • 1.3.5 Molecular Imaging Technologies
    • 1.3.6 Omics Technologies
  • 1.4 Global Medical In-Vitro Toxicology Testing Market by Application
    • 1.4.1 Overview: Global Medical In-Vitro Toxicology Testing Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Chemical Industry
    • 1.4.4 Food Industry
    • 1.4.5 Others
  • 1.5 Global Medical In-Vitro Toxicology Testing Market Size & Forecast
  • 1.6 Global Medical In-Vitro Toxicology Testing Market Size and Forecast by Region
    • 1.6.1 Global Medical In-Vitro Toxicology Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Medical In-Vitro Toxicology Testing Market Size by Region, (2018-2029)
    • 1.6.3 North America Medical In-Vitro Toxicology Testing Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Medical In-Vitro Toxicology Testing Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Medical In-Vitro Toxicology Testing Market Size and Prospect (2018-2029)
    • 1.6.6 South America Medical In-Vitro Toxicology Testing Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Medical In-Vitro Toxicology Testing Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Covance
    • 2.1.1 Covance Details
    • 2.1.2 Covance Major Business
    • 2.1.3 Covance Medical In-Vitro Toxicology Testing Product and Solutions
    • 2.1.4 Covance Medical In-Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Covance Recent Developments and Future Plans
  • 2.2 Bio-Rad Laboratories
    • 2.2.1 Bio-Rad Laboratories Details
    • 2.2.2 Bio-Rad Laboratories Major Business
    • 2.2.3 Bio-Rad Laboratories Medical In-Vitro Toxicology Testing Product and Solutions
    • 2.2.4 Bio-Rad Laboratories Medical In-Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.3 QIAGEN
    • 2.3.1 QIAGEN Details
    • 2.3.2 QIAGEN Major Business
    • 2.3.3 QIAGEN Medical In-Vitro Toxicology Testing Product and Solutions
    • 2.3.4 QIAGEN Medical In-Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 QIAGEN Recent Developments and Future Plans
  • 2.4 Merck
    • 2.4.1 Merck Details
    • 2.4.2 Merck Major Business
    • 2.4.3 Merck Medical In-Vitro Toxicology Testing Product and Solutions
    • 2.4.4 Merck Medical In-Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Merck Recent Developments and Future Plans
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific Medical In-Vitro Toxicology Testing Product and Solutions
    • 2.5.4 Thermo Fisher Scientific Medical In-Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.6 Charles River Laboratories
    • 2.6.1 Charles River Laboratories Details
    • 2.6.2 Charles River Laboratories Major Business
    • 2.6.3 Charles River Laboratories Medical In-Vitro Toxicology Testing Product and Solutions
    • 2.6.4 Charles River Laboratories Medical In-Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.7 Catalent
    • 2.7.1 Catalent Details
    • 2.7.2 Catalent Major Business
    • 2.7.3 Catalent Medical In-Vitro Toxicology Testing Product and Solutions
    • 2.7.4 Catalent Medical In-Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Catalent Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Medical In-Vitro Toxicology Testing Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Medical In-Vitro Toxicology Testing by Company Revenue
    • 3.2.2 Top 3 Medical In-Vitro Toxicology Testing Players Market Share in 2022
    • 3.2.3 Top 6 Medical In-Vitro Toxicology Testing Players Market Share in 2022
  • 3.3 Medical In-Vitro Toxicology Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Medical In-Vitro Toxicology Testing Market: Region Footprint
    • 3.3.2 Medical In-Vitro Toxicology Testing Market: Company Product Type Footprint
    • 3.3.3 Medical In-Vitro Toxicology Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Medical In-Vitro Toxicology Testing Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Medical In-Vitro Toxicology Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Medical In-Vitro Toxicology Testing Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Medical In-Vitro Toxicology Testing Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Medical In-Vitro Toxicology Testing Consumption Value by Type (2018-2029)
  • 6.2 North America Medical In-Vitro Toxicology Testing Consumption Value by Application (2018-2029)
  • 6.3 North America Medical In-Vitro Toxicology Testing Market Size by Country
    • 6.3.1 North America Medical In-Vitro Toxicology Testing Consumption Value by Country (2018-2029)
    • 6.3.2 United States Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Medical In-Vitro Toxicology Testing Consumption Value by Type (2018-2029)
  • 7.2 Europe Medical In-Vitro Toxicology Testing Consumption Value by Application (2018-2029)
  • 7.3 Europe Medical In-Vitro Toxicology Testing Market Size by Country
    • 7.3.1 Europe Medical In-Vitro Toxicology Testing Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 7.3.3 France Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Medical In-Vitro Toxicology Testing Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Medical In-Vitro Toxicology Testing Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Medical In-Vitro Toxicology Testing Market Size by Region
    • 8.3.1 Asia-Pacific Medical In-Vitro Toxicology Testing Consumption Value by Region (2018-2029)
    • 8.3.2 China Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 8.3.5 India Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Medical In-Vitro Toxicology Testing Consumption Value by Type (2018-2029)
  • 9.2 South America Medical In-Vitro Toxicology Testing Consumption Value by Application (2018-2029)
  • 9.3 South America Medical In-Vitro Toxicology Testing Market Size by Country
    • 9.3.1 South America Medical In-Vitro Toxicology Testing Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Medical In-Vitro Toxicology Testing Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Medical In-Vitro Toxicology Testing Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Medical In-Vitro Toxicology Testing Market Size by Country
    • 10.3.1 Middle East & Africa Medical In-Vitro Toxicology Testing Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Medical In-Vitro Toxicology Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Medical In-Vitro Toxicology Testing Market Drivers
  • 11.2 Medical In-Vitro Toxicology Testing Market Restraints
  • 11.3 Medical In-Vitro Toxicology Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Medical In-Vitro Toxicology Testing Industry Chain
  • 12.2 Medical In-Vitro Toxicology Testing Upstream Analysis
  • 12.3 Medical In-Vitro Toxicology Testing Midstream Analysis
  • 12.4 Medical In-Vitro Toxicology Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    The main purpose is to guide the clinical rational use of drugs, reduce adverse drug reactions and reduce the failure of new drug development due to drug toxicity.
    According to our (Global Info Research) latest study, the global Medical In-Vitro Toxicology Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Medical In-Vitro Toxicology Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Medical In-Vitro Toxicology Testing market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Medical In-Vitro Toxicology Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Medical In-Vitro Toxicology Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Medical In-Vitro Toxicology Testing market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Medical In-Vitro Toxicology Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Medical In-Vitro Toxicology Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Covance, Bio-Rad Laboratories, QIAGEN, Merck and Thermo Fisher Scientific, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Medical In-Vitro Toxicology Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Cell Culture Technology
    High Throughput Technology
    Molecular Imaging Technologies
    Omics Technologies
    Market segment by Application
    Pharmaceutical Industry
    Chemical Industry
    Food Industry
    Others
    Market segment by players, this report covers
    Covance
    Bio-Rad Laboratories
    QIAGEN
    Merck
    Thermo Fisher Scientific
    Charles River Laboratories
    Catalent
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Medical In-Vitro Toxicology Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Medical In-Vitro Toxicology Testing, with revenue, gross margin and global market share of Medical In-Vitro Toxicology Testing from 2018 to 2023.
    Chapter 3, the Medical In-Vitro Toxicology Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Medical In-Vitro Toxicology Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Medical In-Vitro Toxicology Testing.
    Chapter 13, to describe Medical In-Vitro Toxicology Testing research findings and conclusion.

    Buy now